FDA Drug Recalls

Recalls / Class III

Class IIID-0528-2025

Product

Pitavastatin Tablets, 1 mg, 90 Tablets per bottle, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478. NDC: 42291-905-90

Brand name
Pitavastatin
Generic name
Pitavastatin Calcium
Active ingredient
Pitavastatin Calcium
Route
Oral
NDCs
42291-905, 42291-906, 42291-907
FDA application
ANDA205932
Affected lot / code info
Lot, expiry: Lot 46208, exp 10/31/2025; Lot 47738, exp 09/30/2026; Lot 46943, exp 05/31/2026;

Why it was recalled

Failed Impurity/Degradation Specifications

Recalling firm

Firm
AvKARE
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
615 N 1st St, Pulaski, Tennessee 38478-2403

Distribution

Quantity
1,560 bottles
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2025-06-26
FDA classified
2025-07-16
Posted by FDA
2025-07-09
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0528-2025. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: Pitavastatin · FDA Drug Recalls